IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma PLC (RPRX)

CUSIP: 00BMVP7Y0 | 1 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

DnB Asset Management AS71,317
0.0% of portfolio›$1.9M
StyleTurnoverLocationFiled
DnB Asset Management AS
71,317$1.9M0.0%CoreMediumOslo, Norway2024-07-05